Ramsay Health Care

2021 International Year of Health & Care Workers

FY21 Result Presentation

12 months ended 30th June 2021

Managing Director & CEO, Craig McNally Group Chief Financial Officer, Martyn Roberts

Important information

The information in this presentation is general background information about Ramsay Health Care Limited and its subsidiaries (Ramsay Group) and their activities and is current as at 26 August 2021. It is in summary form and is not necessarily complete. It should be read together with the company's unaudited consolidated financial statements lodged with the ASX on 26 August 2021. The information in this presentation is general information only and is not intended to be relied upon as advice to investors or potential investors and does not take into account your objectives, financial situation or needs. Investors should consult with their own legal, tax, business and/or financial advisers in connection with any investment decision.

The information in this presentation is believed to be accurate at the time of compilation. Any views expressed in this presentation are opinions of the author at the time of presenting and do not constitute a recommendation to act. No person, including any member of the Ramsay Group, has any responsibility to update any of the information provided in this presentation.

This presentation contains forward looking statements. These forward looking statements should not be relied upon as a representation or warranty, express or implied, as to future matters. Prospective financial information has been based on current expectations about future events and is, however, subject to risks, uncertainties, contingencies and assumptions that could cause actual results to differ materially from the expectations described in such prospective financial information. The Ramsay Group undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this presentation, subject to disclosure obligations under the applicable law and ASX listing rules.

2

FY21 Results Briefing - 12 Months Ended 30 June 2021

Agenda

1.

Key Themes

2.

Response to COVID-19

3.

Group FY21 Financial Highlights

4.

Regional Highlights and Outlook

5.

Group Financials

6.

Strategic Direction and Group Outlook

7.

Questions

For further information please contact:

Kelly Hibbins

Group Head of Investor Relations

Phn: +61 414 609192

Email: HibbinsK@ramsayhealth.com

3 FY21 Results Briefing - 12 Months Ended 30 June 2021

Key Themes

Ramsay employees, doctors and facilities continued to support the public sector and community response to the rapidly changing demands of the COVID environment

Operational and financial metrics reflect pandemic disruption; results improving as the business adapts to the unpredictable operating environment

Balance sheet and cashflow remain strong supporting ongoing investment in the business to drive growth

Continued to develop a strong pipeline of organic growth opportunities and focused on operational excellence through strategic sourcing and optimisation of business processes

Growth and strategic direction focused on leveraging Ramsay's global platform to be a

pre-eminent patient centric integrated healthcare provider

Well positioned to continue to benefit from pent up demand for both private and public healthcare services - vaccination rates and government funding are key

4 FY21 Results Briefing - 12 Months Ended 30 June 2021

Group FY21 Financial Highlights

  • Revenue from patients increased 3.9% and reflects the impact of operational restrictions across the regions due to COVID and lower demand for non surgical services
  • Strong EPS growth reflects the recovery in admissions from the first wave of the pandemic and includes the impact of the $1.5bn capital raising launched in April 2020
  • Earnings include the impact of:
    • Government payments for the use of Ramsay's facilities and services
    • Increased costs associated with operating in a COVID environment
    • A negative impact from case mix reflecting lower demand for non surgical services
  • The balance sheet and cashflow reflect the Spire Healthcare plc (Spire) scheme of arrangement underway at 30th June. Proforma⁵ balance sheet strong, WOFG⁶ leverage below 1x. Net financing costs declined 9.2% and includes swap break costs of $12.5m⁷
  • Fully franked final dividend of 103cps taking the full year dividend to 151.5cps flat on FY19 level. Represents a payout ratio of 79%

Result

$'m

% chg on pcp

Revenue from patients and other revenue

12,435.5

3.9

Total Revenue including govt. support

13,332.3

7.3

EBITDAR¹

2,208.3

11.9

EBITDA²

2,053.5

13.6

EBIT³

1,132.6

29.1

Statutory Net Profit to owners

449.0

58.1

Final dividend per share (DPS) (cps)

103.0

n/a

Full year dividend per share (DPS) (cps)

151.5

142.4

Fully diluted earnings per share (EPS)4 (cps)

192.6

47.6

  1. Earnings before interest, tax, depreciation, amortisation, and rent
  2. Earnings before interest, tax, depreciation and amortisation
  3. Earnings before interest and tax
  4. The denominator for the purpose of calculating earnings per share has been adjusted to reflect the $1.5bn equity raise in the second half of FY20, at less than market value
  5. Proforma assuming that the Spire transaction was not in process at 30th June 2021 refer Slide 17 for further details
  6. Wholly owned funding group (WOFG) excludes Ramsay Santé and Ramsay Sime Darby. Banking covenants calculated on this basis
  7. Swap break costs associated with the refinancing of Ramsay Santé syndicated debt in April 2021

5 FY21 Results Briefing - 12 Months Ended 30 June 2021

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original document
  • Permalink

Disclaimer

Ramsay Health Care Limited published this content on 26 August 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 August 2021 23:20:05 UTC.